About MERLIN BIOTECH INC
Merlin Biotech is a biotechnology company focused on developing novel mRNA-based therapeutics for a wide range of diseases, including cancer and chronic infections. The company's lead program, MER-101, is an mRNA immunotherapy targeting adult solid cancers and pediatric sarcomas.
Development of mRNA-based therapeuticsmRNA delivery via lipid nanoparticles (LNPs)mRNA immunotherapy for oncology, chronic hepatitis B, and preventative Lyme diseaseIntratumoral injection of mRNA for localized treatmentActivation of multiple immunostimulatory pathways
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL MURINE MODEL | Department of Health and Human Services | $355K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MERLIN BIOTECH INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.